Antiphospholipid antibodies in patients with scleroderma: prevalence and clinical significance

Characteristics Limited Diffuse All (n = 18) (n = 7) (n = 25) Calcinosis 2 1 3 Raynaud's phenomenon 17 6 23 Oesophageal dysmotility 9 4 13 Sclerodactyly 17 5 22 Telangiectasia 6 2 8 Pulmonary manifestations 11 5 16 Interstitial lung disease 10 5 15 Pulmonary hypertension 3 0 3 Cardiac manifesta...

Full description

Saved in:
Bibliographic Details
Published in:Annals of the rheumatic diseases 2005-12, Vol.64 (12), p.1795-1796
Main Authors: Sanna, G, Bertolaccini, M L, Mameli, A, Hughes, G R V, Khamashta, M A, Mathieu, A
Format: Article
Language:English
Subjects:
Adult
Aged
anti-β2-glycoprotein I
Antibodies, Antiphospholipid - blood
anticardiolipin antibodies
antiprothrombin antibodies
beta 2-Glycoprotein I
Disease
Family medical history
Female
Glycoproteins - immunology
Health risk assessment
Humans
Immunoglobulins
Letter
Male
Middle Aged
Patients
Phosphatidylserines - immunology
Prothrombin - immunology
Pulmonary hypertension
Rheumatology
Scleroderma
Scleroderma, Systemic - immunology
Thrombosis
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Characteristics Limited Diffuse All (n = 18) (n = 7) (n = 25) Calcinosis 2 1 3 Raynaud's phenomenon 17 6 23 Oesophageal dysmotility 9 4 13 Sclerodactyly 17 5 22 Telangiectasia 6 2 8 Pulmonary manifestations 11 5 16 Interstitial lung disease 10 5 15 Pulmonary hypertension 3 0 3 Cardiac manifestations 1 0 1 Renal manifestations 0 0 0 Bowel disease 0 0 0 *All patients were attending the 2nd Chair of Rheumatology, Rheumatology Division and Centre for Systemic Rheumatic Diseases, Cagliari University Hospital, Cagliari, Italy. aCL, anti-β2GPI, and aPS-PT were detected by enzyme linked immunosorbent assay (ELISA).
ISSN:0003-4967
1468-2060
DOI:10.1136/ard.2005.038430